Suzanne Ildstad

Q: What Schools Are Affiliated With Suzanne Ildstad

Suzanne Ildstad is affiliated with the following schools: University of Kentucky, University of Louisville, Allegheny University of the Health Sciences, University of Pittsburgh

Suzanne Ildstad's AcademicInfluence.com Rankings

Suzanne Ildstad

Biology

#8343

World Rank

#11406

Historical Rank

#2324

USA Rank

Immunology

#655

World Rank

#676

Historical Rank

#95

USA Rank

biology Degrees

Suzanne Ildstad

Philosophy

#9977

World Rank

#13620

Historical Rank

#1803

USA Rank

Logic

#6919

World Rank

#8486

Historical Rank

#969

USA Rank

philosophy Degrees

Download Badge

Biology
Philosophy

Suzanne Ildstad's Degrees

Doctorate Medicine University of Louisville
PhD Immunology University of Louisville

Why Is Suzanne Ildstad Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Suzanne Tollerud Ildstad is an American physician and medical researcher. She is the Chief Scientific Officer and founding CEO of Talaris Therapeutics . She also serves the Board of Directors. She is also the Jewish Hospital Distinguished Professor of Transplantation Research, Director of the Institute for Cellular Therapeutics, Professor in the Department of Surgery with associate appointments in the Departments of Physiology & Biophysics and Microbiology & Immunology at the University of Louisville School of Medicine.

(See a Problem?)

Suzanne Ildstad's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity (1995) (1168)
Cell migration, chimerism, and graft acceptance (1992) (1044)
Cell migration and chimerism after whole‐organ transplantation: The basis of graft acceptance (1993) (808)
Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts (1984) (791)
Chimerism and Tolerance Without GVHD or Engraftment Syndrome in HLA-Mismatched Combined Kidney and Hematopoietic Stem Cell Transplantation (2012) (406)
Systemic chimerism in human female recipients of male livers (1992) (374)
Cells Expressing Early Cardiac Markers Reside in the Bone Marrow and Are Mobilized Into the Peripheral Blood After Myocardial Infarction (2004) (360)
CHIMERISM AND DONOR‐SPECIFIC NONREACTIVITY 27 TO 29 YEARS AFTER KIDNEY ALLOTRANSPLANTATION (1993) (337)
Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. (1994) (311)
Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. (1993) (246)
Duplications of the Alimentary Tract: Clinical Characteristics, Preferred Treatment, and Associated Malformations (1988) (219)
Intracellular labeling of T‐cells with superparamagnetic contrast agents (1993) (192)
Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment (2005) (187)
In Vivo Dynamic MRI Tracking of Rat T‐Cells Labeled with Superparamagnetic Iron‐Oxide Particles (1995) (178)
Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice. (1996) (151)
Tolerance Induction in HLA Disparate Living Donor Kidney Transplantation by Donor Stem Cell Infusion: Durable Chimerism Predicts Outcome (2013) (143)
Cells enriched in markers of neural tissue-committed stem cells reside in the bone marrow and are mobilized into the peripheral blood following stroke (2006) (143)
Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach. (1996) (136)
Small clinical trials : issues and challenges (2001) (113)
Immune Reconstitution/Immunocompetence in Recipients of Kidney Plus Hematopoietic Stem/Facilitating Cell Transplants (2015) (111)
Orthotopic liver transplantation in the mouse. (1991) (110)
Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts. (1995) (103)
Effect of class II antigen matching on renal allograft survival in miniature swine (1984) (99)
Stem Cell-Based Therapeutic Applications in Retinal Degenerative Diseases (2011) (94)
TNF-α Is Critical to Facilitate Hemopoietic Stem Cell Engraftment and Function1 (2008) (94)
Postinfarct Cytokine Therapy Regenerates Cardiac Tissue and Improves Left Ventricular Function (2006) (93)
Science of Composite Tissue Allotransplantation (2008) (89)
Retinal pigment epithelium damage enhances expression of chemoattractants and migration of bone marrow-derived stem cells. (2006) (89)
Antiviral T cell competence and restriction specificity of mixed allogeneic (P1 + P2----P1) irradiation chimeras. (1989) (86)
Donor-specific tolerance induction in composite tissue allografts. (1998) (79)
EVIDENCE THAT NITRIC OXIDE PRODUCTION BY IN VIVO ALLOSENSITIZED CELLS INHIBITS THE DEVELOPMENT OF ALLOSPECIFIC CTL (1992) (78)
Perfusion quantitation in transplanted rat kidney by MRI with arterial spin labeling. (1998) (76)
Production of Donor T Cells Is Critical for Induction of Donor-Specific Tolerance and Maintenance of Chimerism1 (2004) (71)
CD8α+ plasmacytoid precursor DCs induce antigen-specific regulatory T cells that enhance HSC engraftment in vivo. (2011) (70)
Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients. (2006) (69)
Tolerance induction in HLA disparate living donor kidney transplantation by facilitating cell-enriched donor stem cell Infusion: The importance of durable chimerism. (2018) (67)
Glossary of Statistical and Clinical Trials Terms (2001) (67)
Stem cells as tools in regenerative therapy for retinal degeneration. (2009) (64)
Characterization of the immunosuppressive effects of nitric oxide in graft vs host disease. (1993) (63)
Composite tissue transplantation: a rapidly advancing field. (2008) (61)
TNF-alpha is critical to facilitate hemopoietic stem cell engraftment and function. (2008) (61)
Mechanism for cotolerance in nonlethally conditioned mixed chimeras: negative selection of the Vbeta T-cell receptor repertoire by both host and donor bone marrow-derived cells. (1996) (59)
T-cell subsets in healthy teenagers: transition to the adult phenotype. (1990) (59)
Mixed xenogeneic chimerism (mouse+rat-->mouse) to induce donor-specific tolerance to sequential or simultaneous islet xenografts. (1994) (58)
Mixed allogeneic chimerism and tolerance to composite tissue allografts (2000) (57)
Donor dendritic cell repopulation in recipients after rat-to-mouse bone-marrow transplantation (1992) (56)
Composite tissue allotransplantation: past, present and future-the history and expanding applications of CTA as a new frontier in transplantation. (2009) (56)
Endogenous bone marrow derived cells express retinal pigment epithelium cell markers and migrate to focal areas of RPE damage. (2007) (53)
Leukocyte iNOS is required for inflammation and pathological remodeling in ischemic heart failure (2017) (53)
Flt3-ligand treatment prevents diabetes in NOD mice. (2004) (49)
EVIDENCE FOR EARLY Th 2 T CELL PREDOMINANCE IN XENOREACTIVITY (1993) (49)
Transplantation of the hand, face, and composite structures: evolution and current status. (2007) (46)
Composite tissue allotransplantation: current challenges. (2009) (46)
Systemically transferred hematopoietic stem cells home to the subretinal space and express RPE-65 in a mouse model of retinal pigment epithelium damage. (2006) (45)
The history of human composite tissue allotransplantation. (2009) (43)
Chimerism and tolerance: from freemartin cattle and neonatal mice to humans. (1997) (43)
Evolving Approaches of Hematopoietic Stem Cell–Based Therapies to Induce Tolerance to Organ Transplants: The Long Road to Tolerance (2013) (43)
Composite tissue allotransplantation in chimeric hosts: part I. prevention of graft-versus-host disease1 (2003) (43)
Bone Marrow Transplantation Temporarily Improves Pancreatic Function in Streptozotocin-Induced Diabetes: Potential Involvement of Very Small Embryonic-Like Cells (2010) (43)
Plasmacytoid Dendritic Cells Regulate Autoreactive B Cell Activation via Soluble Factors and in a Cell-to-Cell Contact Manner1 (2009) (43)
Effect of FLT3 ligand and granulocyte colony-stimulating factor on expansion and mobilization of facilitating cells and hematopoietic stem cells in mice: kinetics and repopulating potential. (1998) (41)
Cardiac contusion in pediatric patients with blunt thoracic trauma. (1990) (41)
A Multivariate Analysis of Determinants of Survival for Patients with Squamous Cell Carcinoma of the Head and Neck (1989) (40)
Graft facilitating cells are derived from hematopoietic stem cells and functionally require CD3, but are distinct from T lymphocytes. (2004) (39)
Mixed hematopoietic chimerism induces donor-specific tolerance for lung allografts in rodents. (1999) (38)
Long-term survival of donor-specific pancreatic islet xenografts in fully xenogeneic chimeras (WF rat----B10 mouse). (1992) (35)
Regulatory B cells: the new "it" cell. (2014) (35)
Facilitating cells as a venue to establish mixed chimerism and tolerance (2003) (34)
Impact of Bone Marrow Transplantation on Type I Diabetes (2001) (34)
CD45 Congenic Bone Marrow Transplantation: Evidence for T Cell–Mediated Immunity (2004) (33)
Facilitating cells enable engraftment of purified fetal liver stem cells in allogeneic recipients. (1996) (33)
Matching at the MHC class I K locus is essential for long-term engraftment of purified hematopoietic stem cells: a role for host NK cells in regulating HSC engraftment. (2004) (32)
Squamous cell carcinoma of the tongue: a comparison of the anterior two thirds of the tongue with its base. (1983) (31)
The Abrogation of Allosensitization Following the Induction of Mixed Allogeneic Chimerism1 (2000) (30)
In vivo depletion of host CD4+ and CD8+ cells permits engraftment of bone marrow stem cells and tolerance induction with minimal conditioning. (1997) (30)
Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts. (1998) (29)
Mixed allogeneic chimerism prevents obstructive airway disease in a rat heterotopic tracheal transplant model. (1998) (29)
MIXED ALLOGENEIC RECONSTITUTION (A+B→A) TO INDUCE DONOR‐SPECIFIC TRANSPLANTATION TOLERANCE: PERMANENT ACCEPTANCE OF A SIMULTANEOUS DONOR SKIN GRAFT (1991) (28)
Waiting for organ transplantation: results of an analysis by an Institute of Medicine Committee. (2003) (28)
Costimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization. (2008) (28)
A partial conditioning approach to achieve mixed chimerism in the rat: depletion of host natural killer cells significantly reduces the amount of total body irradiation required for engraftment. (1999) (28)
A partial conditioning strategy for achieving mixed chimerism in the rat: tacrolimus and anti-lymphocyte serum substantially reduce the minimum radiation dose for engraftment. (1998) (28)
CD8+, αβ-TCR+, and γδ-TCR+ Cells in the Recipient Hematopoietic Environment Mediate Resistance to Engraftment of Allogeneic Donor Bone Marrow1 (2002) (28)
Stem cell-based strategies for the treatment of type 1 diabetes mellitus (2011) (28)
Effect of FLT3 Ligand and Granulocyte Colony-Stimulating Factor on Expansion and Mobilization of Facilitating Cells and Hematopoietic Stem Cells in Mice: Kinetics and Repopulating Potential (1998) (27)
Identification of inducible nitric oxide synthase in peripheral blood cells as a mediator of myocardial ischemia/reperfusion injury (2012) (27)
Intra-oral cancer at the Massachusetts General Hospital. Squamous cell carcinoma of the floor of the mouth. (1983) (27)
The role of alphabeta- and gammadelta-T cells in allogenic donor marrow on engraftment, chimerism, and graft-versus-host disease. (2001) (26)
Dissociation Between Peripheral Blood Chimerism and Tolerance to Hindlimb Composite Tissue Transplants: Preferential Localization of Chimerism in Donor Bone (2009) (26)
Preconditioning of NOD mice with anti-CD8 mAb and costimulatory blockade enhances chimerism and tolerance and prevents diabetes, while depletion of alpha beta-TCR+ and CD4+ cells negates the effect. (2005) (26)
Evidence That FoxP3+ Regulatory T Cells May Play a Role in Promoting Long-Term Acceptance of Composite Tissue Allotransplants (2011) (25)
T-cell depletion of allogeneic bone marrow using anti-alphabetaTCR monoclonal antibody: prevention of graft-versus-host disease without affecting engraftment potential in rats. (1999) (24)
Immunosuppressive protocols and immunological challenges related to hand transplantation. (2011) (23)
Mixed allogeneic chimerism. Past, present, and prospects for the future. (2001) (22)
DOCK2 Is Critical for CD8+TCR− Graft Facilitating Cells to Enhance Engraftment of Hematopoietic Stem and Progenitor Cells (2014) (21)
Alloresistance to engraftment of allogeneic donor bone marrow is mediated by an Lyt-2+ T cell in mixed allogeneic reconstitution (C57BL/10Sn + B10.D2/nSn----C57BL/10Sn) (1986) (21)
Addition of Cyclophosphamide to T-cell Depletion–Based Nonmyeloablative Conditioning Allows Donor T-cell Engraftment and Clonal Deletion of Alloreactive Host T-cells After Bone Marrow Transplantation (2007) (20)
HSCT-Based Approaches for Tolerance Induction in Renal Transplant. (2017) (20)
Chimerism and tolerance (1995) (19)
Squamous cell carcinoma of the mobile tongue. Clinical behavior and results of current therapeutic modalities. (1983) (19)
Baboon Bone-Marrow Xenotransplant in a Patient with Advanced HIV Disease: Case Report and 8-Year Follow-Up (2004) (19)
Facilitating cells: novel promoters of stem cell alloengraftment and donor-specific transplantation tolerance in the absence of GVHD. (2007) (19)
Squamous Cell Carcinoma of the Alveolar Ridge and Palate: A 15‐year Survey (1984) (18)
Plasmacytoid Dendritic Cells Regulate Autoreactive B Cell Activation via Soluble Factors and in a Cell-to-Cell Contact Manner (2009) (18)
A nonlethal conditioning approach to achieve engraftment of xenogeneic rat bone marrow in mice and to induce donor-specific tolerance. (1998) (18)
THE REQUIREMENT FOR ALLOGENEIC CHIMERISM FOR SECOND TRANSFER OF TOLERANCE FROM MIXED ALLOGENEIC CHIMERAS (A + B → A) TO SECONDARY RECIPIENTS (1992) (17)
The Need for Inducing Tolerance in Vascularized Composite Allotransplantation (2012) (16)
Allograft and Xenograft Acceptance under FK‐506 and Other Immunosuppressant Treatment a (1993) (16)
Xenotransplantation for AIDS (1996) (16)
The influence of donor age on graft survival in renal transplantation. (1990) (15)
COMMITTEE ON STRATEGIES FOR SMALL-NUMBER-PARTICIPANT CLINICAL RESEARCH TRIALS (2001) (15)
Transplantation: Is donor T-cell engraftment a biomarker for tolerance? (2012) (15)
Simultaneous Bone Marrow and Composite Tissue Transplantation in Rats Treated With Nonmyeloablative Conditioning Promotes Tolerance (2013) (15)
Plasmacytoid Precursor Dendritic Cells From NOD Mice Exhibit Impaired Function (2008) (15)
Facilitating cells in tolerance induction for kidney transplantation (2015) (14)
The role of pDC, recipient Treg, and donor Treg in HSC engraftment (2011) (14)
CULTURE OF DENDRITIC CELLS FROM MURINE BONE MARROW SUPPLEMENTED WITH GM-CSF AND TNF-ALPHA (1994) (14)
XENOTRANSPLANTATION: APPLICATION OF DISEASE RESISTANCE (1999) (14)
Mixed Xenogeneic Chimerism Induces Donor-Specific Humoral and Cellular Immune Tolerance for Cardiac Xenografts1 (2004) (14)
Delayed Donor Bone Marrow Infusion Induces Liver Transplant Tolerance (2017) (13)
NK Cells Play a Critical Role in the Regulation of Class I-Deficient Hemopoietic Stem Cell Engraftment: Evidence for NK Tolerance Correlates with Receptor Editing1 (2005) (13)
Addition of a bone marrow "facilitating cell" population increases stem cell-derived cobblestone area formation in impaired long-term bone marrow culture stroma. (1998) (13)
Immunology of vascularized composite allotransplantation: a primer for hand surgeons. (2012) (13)
Hematopoietic chimerism, tolerance induction and graft-versus-host disease: considerations for composite tissue transfer. (1998) (13)
αβTCR+ T cells play a nonredundant role in the rejection of heart allografts in mice (1999) (13)
Mixed xenogeneic chimerism and tolerance III. A nonlethal approach to induce donor-specific transplantation tolerance to simultaneous islet xenografts. (1995) (13)
Baboon Bone Marrow Transplantation in Humans: Application of Cross-Species Disease Resistance (1997) (12)
Novel regulatory therapies for prevention of Graft-versus-host disease (2012) (12)
Islet xenografts in fully xenogeneic (rat----mouse) chimeras: evidence for normal regulation of function in a xenogeneic mouse environment. (1992) (12)
Innate and Adaptive Immune Responses Are Tolerized in Chimeras Prepared With Nonmyeloablative Conditioning (2012) (12)
Hematopoietic stem cells from NOD mice exhibit autonomous behavior and a competitive advantage in allogeneic recipients. (2005) (12)
Clinical behavior and results of current therapeutic modalities for squamous cell carcinoma of the buccal mucosa. (1985) (12)
The beneficial effects of postinfarct cytokine combination therapy are sustained during long-term follow-up. (2009) (12)
Mixed Allogeneic Chimerism to Induce Tolerance to Solid Organ and Cellular Grafts (1999) (12)
Bone marrow transplantation for therapy in autoimmune disease (1997) (11)
Bone Marrow Cell Graft Engineering: From Bench to Bedside (2001) (11)
CD4+ T CELLS, BUT NOT CD8+ T CELLS, MEDIATE THE BREAKING OF TOLERANCE IN MIXED ALLOGENEIC CHIMERAS (B10 + B10.BR ± B10) (1993) (11)
Squamous cell carcinoma of the head and neck at the Massachusetts General Hospital: a comparison of biologic characteristics in men and women. (1986) (11)
Clinical Applications of Mixed Chimerism (1999) (11)
Is durable macrochimerism key to achieving clinical transplantation tolerance? (2011) (11)
HLA identical non-chimeric and HLA disparate chimeric renal transplant tolerance. (2013) (10)
Intrapancreatic islet transplantation as a potential solution to chronic failure of intraportal islet grafts. (1993) (10)
Facilitating cells: Translation of hematopoietic chimerism to achieve clinical tolerance (2015) (10)
Past, present, and future prospects for inducing donor-specific transplantation tolerance for composite tissue allotransplantation. (2007) (10)
No cheers for baboon to AIDS patient xenotransplant (1995) (10)
Flt3‐Ligand–Mobilized Peripheral Blood, but Not Flt3‐Ligand–Expanded Bone Marrow, Facilitating Cells Promote Establishment of Chimerism and Tolerance (2006) (9)
A Clinically Feasible Approach to Induce Delayed Tolerance in Recipients of Prior Kidney or Vascularized Composite Allotransplants (2012) (9)
Flt 3-Ligand Treatment Prevents Diabetes in NOD Mice (2004) (9)
A delay in bone marrow transplantation after partial conditioning improves engraftment1 (2004) (9)
Hematopoietic stem cells from the marrow of mice treated with Flt3 ligand are significantly expanded but exhibit reduced engraftment potential. (2002) (8)
Intragraft Molecular Pathways Associated with Tolerance Induction in Renal Transplantation. (2017) (8)
Tolerance induction for islet transplantation. (1997) (8)
A Critical Role for the TLR4/TRIF Pathway in Allogeneic Hematopoietic Cell Rejection by Innate Immune Cells (2013) (8)
A minimal conditioning approach to achieve stable multilineage mouse plus rat chimerism. (1995) (8)
LONG-TERM FOLLOW-UP OF A PHASE 2 CLINICAL TRIAL TO INDUCE TOLERANCE IN LIVING DONOR RENAL TRANSPLANT RECIPIENTS (2018) (8)
Intrathymic transplantation of hepatocytes is facilitated by the addition of pancreatic islets. (1992) (7)
FK506 inhibits the differentiation of developing thymocytes but not negative selection of T cell receptor Vβ5+ and Vβ;11+ T lymphocytes in vivo (1994) (7)
Small Clinical Trials (2001) (7)
The role of pDC, recipient T(reg) and donor T(reg) in HSC engraftment: Mechanisms of facilitation. (2011) (7)
Chimerism and the facilitating cell (1995) (7)
Tolerance to organ transplants: is chimerism bringing it closer than we think? (2007) (7)
Chimerism and Tolerance Without GVHD in Mismatched Recipients of Combined Hematopoietic Stem Cell/Kidney Transplants: Donor-Specific Hyporeactivity Is Not a Reliable Biomarker for Tolerance.: Abstract# C2094 (2014) (7)
Design of Small Clinical Trials (2001) (7)
Establishment of fully xenogeneic (mouse-->rat) bone marrow chimeras: evidence for normal development and clonal deletion of mouse T cells. (2000) (7)
High apical insertion of the right diaphragm in an infant with right-sided Bochdalek diaphragmatic hernia. (1990) (6)
Kinetics of early T-cell repopulation in the mouse following syngeneic bone marrow transplantation: FK 506 causes a maturational defect of CD4+ CD8- T cells. (1991) (6)
Spontaneous Operational Tolerance in Kidney Transplant Recipients (2012) (6)
Intra‐oral Cancer at the Massachusetts General Hospital Squamous Cell Carcinoma of the Floor of the Mouth (1983) (5)
THE ROLE OF-AND -T CELLS IN ALLOGENEIC DONOR MARROW ON ENGRAFTMENT, CHIMERISM, AND GRAFT-VERSUS- HOST DISEASE (2001) (5)
INDUCTION OF DONOR SPECIFIC TOLERANCE IN RECIPIENTS OF HLA DISPARATE LIVING DONOR KIDNEY ALLOGRAFTS BY DONOR STEM CELL INFUSION: 2660 (2010) (5)
A Critical Role for Innate Immunity In Allogeneic Hematopoietic Cell Rejection Via the TLR4/TRIF Pathway (2010) (5)
A complex case of jejunoileocolic atresias. (1990) (5)
Current progress in chimerism and donor-specific tolerance. (1996) (4)
Effects of FK 506 on chimerism and the induction of donor-specific unresponsiveness following fully allogeneic bone marrow transplantation in mice. (1995) (4)
Alpha beta TCR+ T cells play a nonredundant role in the rejection of heart allografts in mice. (1999) (4)
A Phase 2 Clinical Trial of Donor Specific Tolerance Induction in Recipients of HLA Disparate Living Donor Kidney Allografts by Donor Stem Cell Infusion: 444 (2012) (4)
Strategic Nonmyeloablative Conditioning: CD154:CD40 Costimulatory Blockade at Primary Bone Marrow Transplantation Promotes Engraftment for Secondary Bone Marrow Transplantation after Engraftment Failure1 (2008) (4)
Positive and negative selection of alphabetaTCR+ T cells in thymectomized adult radiation bone marrow chimeras. (1999) (4)
Composite tissue allograft (CTA): tolerance induction without graft vs host disease (GvHD) (2000) (4)
Induction of Pancreatic Islet Graft Acceptance: The Role of Antigen Presenting Cells. (1992) (4)
Fms-Related Tyrosine Kinase 3 Expression Discriminates Hematopoietic Stem Cells Subpopulations With Differing Engraftment-Potential: Identifying the Most Potent Combination (2008) (4)
CHARACTERIZATION OF MATURATION AND FUNCTION OF NATURAL KILLER CELLS IN XENOGENEIC (RAT ± MOUSE) BONE MARROW CHIMERAS: EVIDENCE THAT RAT NK CELLS ARE PRESENT AND FUNCTIONAL IN A XENOGENEIC ENVIRONMENT (1993) (4)
A novel role of innate immune responses (toll-like receptor-4) in triggering graft-versus-host disease. (2010) (3)
A GRAFT ENGINEERING METHOD TO ALLOW BONE MARROW TRANSPLANTATION (BMT) FOR MORE HIGHLY MISMATCHED RECIPIENTS WITH LEUKEMIA: MULTIVARIATE ANALYSIS OF A PHASE I/II PROTOCOL.: Abstract# 702 (2000) (3)
The role of bone marrow transplantation in tolerance: organ-specific and cellular grafts (1999) (3)
Differential outcomes in prediabetic vs. overtly diabetic NOD mice nonmyeloablatively conditioned with costimulatory blockade. (2011) (3)
FACILITATING CELL ENRICHED STEM CELL INFUSION RESULTS IN DURABLE CHIMERISM, DONOR SPECIFIC TOLERANCE, AND ALLOWS FOR IMMUNOSUPPRESSIVE DRUG WITHDRAWAL IN RECIPIENTS OF HLA DISPARATE LIVING DONOR KIDNEY ALLOGRAFTS: 3375 (2010) (3)
Chimerism and Tolerance in Solid Organ Transplantation (2013) (3)
Cellular transplantation and gene therapy. (1993) (3)
215.10: Tolerant Kidney Transplant Recipients Display a Unique CTLA-4 Dominant Urinary Cell mRNA Signature (2022) (2)
Leukodystrophy and Bone Marrow Transplantation: Role of Mixed Hematopoietic Chimerism (1999) (2)
Critical Role for DOCK2 in CD8+/TCR− Graft Facilitating Cells Enhancing Engraftment of Hematopoietic Stem Cells (2011) (2)
Fms‐Like Tyrosine Kinase 3‐Ligand Contributes to the Development and Function of the Subpopulation of CD8α+ Plasmacytoid Precursor Dendritic Cells in CD8+/TCR− Facilitating Cells (2018) (2)
Statistical Approaches to Analysis of Small Clinical Trials (2001) (2)
Renal transplantation in pediatric recipients. (1989) (2)
New concepts in immunobiology (1995) (2)
Mechanisms of specific acceptance of skin grafts in mixed allogeneically and xenogeneically reconstituted mice (1985) (2)
Multicentric Wilms' Tumor with Contralateral Recurrence: Comments on Management (1988) (1)
ALEMTUZUMAB INDUCTION IN HAND TRANSPLANTATION: PROGRESS TOWARDS MINIMIZING IMMUNOSUPPRESSION IN COMPOSITE TISSUE ALLOTRANSPLANTATION (CTA): 2292 (2008) (1)
Allogeneic Hematopoietic Cell Therapies to Induce Tolerance in Kidney Transplantation (2018) (1)
FL/GCSF/AMD3100-mobilized Hematopoietic Stem Cells Induce Mixed Chimerism With Nonmyeloablative Conditioning and Transplantation Tolerance. (2019) (1)
CD8+TCR- Graft Facilitating Cells Prime Migration and Enhance Homing of Hematopoietic Stem Cells.: Abstract# D2776 (2014) (1)
Does the End Justify the Means? An Analysis of Outcomes in Recipients of Combined Kidney/Hematopoietic Stem Cell (HSC) Transplants and Comparison to Standard of Care (SOC) Patients (2018) (1)
Establishment of Durable Chimerism with Minimal GvHD in Highly Mismatched Recipients Receiving an Investigational Facilitated Allo-HSCT (2021) (1)
FK506 inhibits the differentiation of developing thymocytes but not negative selection of T cell receptor V beta 5+ and V beta 11+ T lymphocytes in vivo. (1994) (1)
lymphodepletion results in prevention of allogeneic sensitization Costimulatory blockade of CD154-CD40 in combination with T-cell (2013) (1)
BLOCKADE OF T CELL CO‐STIMULATION IN VIVO ALLOWS CHIMERISM WITH DECREASED CONDITIONING IN DIABETES‐PRONE NOD MICE.: Abstract# 944 Poster Board #‐Session: P201‐III (2000) (1)
Xenotransplantation: a step closer to reality? (2007) (1)
A Critical Role for TGF-&bgr;/Fc and Nonlytic IL-2/Fc Fusion Proteins in Promoting Chimerism and Donor-Specific Tolerance (2017) (1)
Xenotransplantation: Basic Research and Clinical Applications.Edited byJeffrey L Platt.Totowa (New Jersey): Humana Press.$125.00. x + 270 p; ill.; index. ISBN: 0–89603–674‐X. 2002. (2003) (1)
HLA-Mismatched Combined Kidney and Hematopoietic Stem Cell Chimerism and Tolerance Without GVHD or Engraftment Syndrome in (2012) (1)
Graft tolerance and acceptance in xenotransplantation (2002) (1)
Chimeric Regulatory T cells Enhance HSC Engraftment in An Antigen-Specific Fashion. (2009) (1)
Update On Phase 2 Clinical Trial To Induce Tolerance In Mismatched Living Donor Renal Transplant Recipients (2013) (1)
Renal transplantation in the highly sensitized recipient. (1987) (1)
Percutaneous transperineal pouch localization in low imperforate anus: a new approach. (1990) (1)
Bone marrow chimerism and pancreatic islet grafts (1992) (1)
Immune Reconstitution in Recipients of Living Donor Kidney/Hematopoietic Stem + Facilitating Cell Transplants (2014) (1)
Promotion of Chimerism and Tolerance by Flt3 Ligand-Mobilized Facilitating Cells Is Associated with Upregulation of CXCR4 and SDF-1. (2004) (1)
DONOR MARROW INFUSION IN KIDNEY TRANSPLANTATION: RESULTS OF PRELIMINARY STUDY: 208 (2008) (1)
CD8 α+ PLASMACYTOID PRECURSOR DC INDUCE ANTIGEN-SPECIFIC REGULATORY T CELLS IN VIVO THAT POTENTLY ENHANCE HSC ENGRAFTMENT: 295 (2010) (0)
215.8: Long-term Follow-up of a Phase 2 Clinical Trial to Induce Tolerance in Living Donor Renal Transplant Recipients (2022) (0)
CD8+TCR- Bone Marrow Facilitating Cells Prime Migration and Enhance Homing of Hematopoietic Stem Cells (2014) (0)
CD8+/TCR- Graft Facilitating Cells Enhance Homing of Hematopoietic Stem Cells: 459 (2012) (0)
Costimulatory Blockade Enhances Engraftment and Prevents Anti-Donor Antibody Generation in Nonmyeloablative Conditioned Prediabetic NOD Mice (2008) (0)
Requirements for Hematopoietic Stem Cell Engraftment and Graft Engineering: Role of Facilitating Cells (2000) (0)
Sensitization to Minor Histocompatibility Antigens Poses a Barrier in Transplantation and Can Be Prevented by CD154:CD40 Co-Stimulatory Blockade. (2008) (0)
STEM CELL CHIMERISM AND TOLERANCE INDUCTION (2001) (0)
INFILTRATION OF REGULATORY T CELLS IN THE TOLERANT SKIN OF ALLOGRAFT IN A RAT HIND-LIMB TRANSPLANTATION MODEL: 386 (2008) (0)
Plasmacytoid Precursor Dendritic Cells Contribute to the Ability of CD8 + TCR − Facilitating Cells Population of Enhance Hematopoetic Stem Cell Engraftment and HSC Clonogenicity. (2004) (0)
Rat peripheral T-cell receptor V beta repertoire in F344-to-B10 (rat-to-mouse) mixed xenogeneic chimeras. (1999) (0)
NOD Hematopoietic Stem Cells Exhibit Autonomous Behavior and a Competitive Advantage in Allogeneic Recipients That Maps to the Idd9 Locus. (2004) (0)
Hematopoietic stem cells from NOD mice exhibit autonomous behavior and a competitive advantage in allogeneic recipients Running Head: HSC from NOD mice are autonomous (2004) (0)
EX-VIVO GENERATION OF FACILITATING CELLS. (1998) (0)
Facilitating Cells: A Journey from Bench to Bedside (2018) (0)
CORRELATION OF INTRADERMAL REGULATORY T CELLS AND QUIESCENCE WITH RESPECT TO REJECTION IN HAND TRANSPLANTS WITH LONG TERM FOLLOW UP. (2006) (0)
113-P: TCR REPERTOIRE AS A BIOMARKER FOR CHIMERIC KIDNEY RECIPIENTS BENEFITING FROM FACILITATING CELL-ENRICHED STEM CELL TRANSPLANTATION (2013) (0)
Hematopoietic facilitatory cells and use thereof (1993) (0)
Reduced Inflammatory But Normal Cell Maintenance Transcripts in Tolerant Kidney Transplant Biopsies.: Abstract# A499 (2014) (0)
FUNCTIONAL CHARACTERIZATION OF GRAFT FACILITATING CELLS:MICE LACKING CD3&egr;, CLASS I, CD8 &agr; AND PERFORIN PRODUCTION DO NOT EXHIBIT GRAFT FACILITATION.: Abstract# 655 (2000) (0)
SHORT- AND LONG-TERM ENGRAFTMENT-POTENTIAL OF MOBILIZED FACILITATING CELLS AND HEMATOPOIETIC STEM CELLS ACROSS MHC-BARRIERS. (1998) (0)
Regulatory B Cells Promote Engraftment in Allogeneic Hematopoietic Stem Cell Transplantation.: Abstract# 2945 (2014) (0)
Xenoreactions and their modulation with bone marrow transplantation to induce tolerance (1999) (0)
This information is current as Tolerance Correlates with Receptor Editing Stem Cell Engraftment: Evidence for NK Regulation of Class I-Deficient Hemopoietic NK Cells Play a Critical Role in the (2013) (0)
Mixed multilineage chimerism in CD8-Knockout mice following allogeneic bone marrow transplantation with partial conditioning. (1998) (0)
BONE MARROW TRANSPLANTATION TEMPORARILY IMPROVES THE FUNCTION OF PANCREAS IN STREPTOZOTOCIN-INDUCED DIABETES: 460 (2008) (0)
Monoclonal antibodies against antigens that are expressed by hematopoietic helper cells (1995) (0)
Hematopoietic stem cells migrate into the subretinal space in a model of retinal pigment epithelium loss (2004) (0)
DOCK2 Is Critical for FC to Induce Regulatory T Cells (2012) (0)
A PARTIAL CONDITIONING STRATEGY TO ACHIEVE STABLE MIXED CHIMERISM IN THE RAT: CD8+ AND NK+ CELLS IN THE RECIPIENT MICROENVIRONMENT CONTRIBUTE TO ALLORESISTANCE TO ENGRAFTMENT.: Abstract# 941 Poster Board #‐Session: P198‐III (2000) (0)
INFLUENCE OF COMPOSITION OF BONE MARROW ON LEVEL OF CHIMERISM AND INCIDENCE OF GRAFT-VERSUS-HOST DISEASE: EVIDENCE FOR A FACILITATING CELL POPULATION (1999) (0)
279: CD154:CD40 co-stimulatory blockade at primary BMT promotes allogeneic engraftment in secondary BMT by blocking sensitization (2007) (0)
Monoclonal Antibody Treatment for the Induction of Hematopoietic Stem Cell Chimerism In Type 1 Diabetic Mice (1999) (0)
Chimerism: A Clinical Guide to Tolerance Induction (2018) (0)
Human Facilitating Cells (FCs): Two Distinct, Complementary, and Synergistic CD56 Subpopulations That Uniquely Define FC Function (2014) (0)
Absence of systemic donor specific transplantation tolerance despite long term survival of small bowel allografts (1990) (0)
Co-stimulatory blockade of CD154:CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization Running Title: CD154 blockade prevents allogeneic sensitization (2007) (0)
PROLONGED SURVIVAL OF CLASS II MATCHED RENAL ALLOGRAFTS expression of class II (2003) (0)
SUMMARY OF A PHASE II PROTOCOL TO ATTEMPT TO INDUCE MIXED CHIMERISM AND DONOR‐SPECIFIC TOLERANCE TO RENAL AND CARDIAC ALLOGRAFTS.: Abstract# 703 (2000) (0)
MECHANISM OF FC ACTION: FACILITATING CELLS ENHANCE THE CLONOGENICITY OF HUMAN HEMATOPOIETIC STEM CELLS IN VITRO: 457 (2008) (0)
A PARTIAL CONDITIONING MODEL TO ACHIEVE HEMATOPOIETIC STEM CELL (HSC) CHIMERISM IN MICE WITH TYPE 1 DIABETES (1998) (0)
Hematopoietic stem cells from the marrow of mice treated with flt3 ligand are significantly expanded but exhibit reduced engraftment potential1 (2002) (0)
Disparate immune responses to Mi-HAg occur in vitro and in vivo (141.1) (2009) (0)
FLT3-LIGAND TREATMENT OF MICE REDUCES THE PROPORTION OF T AND B CELLS AND INCREASES DENDRITIC CELLS, STEM CELLS AND FACILITATING CELLS IN THE BONE MARROW (1999) (0)
DEVELOPMENT OF NKR-P1dim/αβTCR+ CELL IS NOT THYMIC DEPENDENT IN XENOGENEIC (RAT-->MOUSE) CHIMERAS. † 924 (1996) (0)
Abstract 221: The Beneficial Effects of Cytokine Combinations are Sustained During Long-term Follow-up (2006) (0)
Cross-species Transplantation Tolerance: Rat Bone Marrow-derived Cells Can Contribute to the Ligand for Negative Selection of' Mouse T Cell Receptor V~ in Chimeras Tolerant to Xenogeneic Antigens (2003) (0)
Composite tissue transplantation: tolerance through hematopoietic chimerism (2003) (0)
Immune Monitoring in Recipients of a Combined Solid Organ and Facilitating Cell-Enriched Stem Cell Transplant: Durable Chimerism Predicts Outcome: 445 (2012) (0)
LONG-TERM SURVIVAL OF DONOR-SPECIFIC PANCREATIC ISLET XENOGRAFTS IN FULLY XENOGENEIC CHIMERAS ( WF RAT → B 10 MOUSE ) (2010) (0)
The Ratio of CTLA4 to Perforin and Granzyme B as a Potential Biomarker of Tolerance in Chimeric Renal Transplant Patients (2018) (0)
A SUBSTANTIAL LEVEL OF CHIMERISM COMBINED WITH DONOR T CELL PRODUCTION IS REQUIRED FOR THE INDUCTION AND MAINTENANCE OF TOLERANCE OF COMPOSITE TISSUE ALLOGRAFTS. (2006) (0)
HLA MOLECULAR MISMATCH ANALYSIS IN PATIENTS RECEIVING KIDNEY AND THE HEMATOPOIETIC STEM / FACILITATING CELL INDUCTION PROTOCOL (2020) (0)
CD154:CD40 Co-Stimulatory Blockade: A Specific Approach To Prevent Sensitization to Donor Alloantigens. (2005) (0)
LONG‐TERM SURVIVAL OF DONOR‐SPECIFIC PANCREATIC ISLET XENOGRAFTS IN FULLY XENOGENEIC CHIMERAS (WF RAT‐B10 MOUSE) 1, 2 (1992) (0)
FK 506 treatment following syngeneic bone marrow transplantation does not inhibit clonal deletion of V beta 5+ or V beta 11+ T cells. (1992) (0)
STEROID ELIMINATION DURING LONG TERM FOLLOW-UP IN HAND TRANSPLANTATION: 2291 (2008) (0)
Novel regulatory therapies for treatment and prevention of GVHD (2012) (0)
Use of a Processed Hematopoietic Stem Cell Product (FCRx) in Unmatched Related and Unrelated Donor — Recipient Pairs Is Associated with High Levels of Donor Chimerism and Donor-Specific Tolerance to Kidney Allografts (2018) (0)
Durable Chimerism, Absence of Graft-Versus-Host Disease and the Induction of Donor Specific Tolerance in Recipients of HLA Disparate Living Donor Kidney Transplants and Therapeutic Cell Transfer (2011) (0)
Host CD8+ cells play a major role in resistance to engraftment of bone marrow for Tolerance induction (1998) (0)
A new method for preservation of multiple short segments of viable bowel in massive small bowel necrosis (1991) (0)
TGF-ß PLAYS A CRITICAL ROLE IN PROMOTING CHIMERISM AND TOLERANCE: 236 (2010) (0)
THE ROLE OF &agr;&bgr;- AND &ggr;&dgr;-T CELLS IN ALLOGENEIC DONOR MARROW ON ENGRAFTMENT, CHIMERISM, AND GRAFT-VERSUS-HOST DISEASE1 (2001) (0)
Hematopoietic Stem Cell Chimerism and Tolerance Induction (2001) (0)
CD8+/TCR− Graft Facilitating Cells Enhance HSC Engraftment and Survival Via TNF-α Mediated Prevention of Apoptosis. (2005) (0)
Results Cell Surface Phenotype of Syngeneic Bone Marrow Cell Responsible for Alloresistance to Engraftment in Mixed Allogeneic Reconstitution (2003) (0)
CXCR4+ CD45− Tissue-Committed Stem Cells (TCSC) for Myocardium Reside in the Bone Marrow, Are Mobilized into the Peripheral Blood during Myocardial Infarction, and “Home” to Infarcted Myocardium in CXCR4-SDF-1 and HGF/SF-c-Met Dependent Manner. (2004) (0)
Human facilitating cells and applications thereof. (2011) (0)
Immunocompetence in Recipients of Hematopoietic Stem Cell/Renal Transplants.: Abstract# C2092 (2014) (0)
A Single-Arm, Multicenter, Exploratory, Safety and Efficacy Study of FCR001 Cell-Based Therapy to Induce Donor-Specific Tolerance in Previously Transplanted Recipients of a Kidney from a Living Donor, and Safety in FCR001 Donors (FREEDOM-2 study) (2023) (0)
Hematopoietic Mononuclear Cell Transplant with Minimal Gvhd in up to Completely Mismatched Unrelated Recipients (2019) (0)
Chimerism and Tolerance as an Approach to Xenotransplantation (1997) (0)
Chimerism Correlates With Shifts in TCR Repertoire in Recipients of Facilitating Cell-Enriched Hematopoietic Stem Cell/Renal Transplants.: Abstract# 1433 (2014) (0)
PREFERENTIAL DISTRIBUTION OF FOXP3+ REGULATORY T CELLS IN COMPOSITE TISSUE ALLOGRAFTS: 1453 (2008) (0)
Facilitating cells: role in inducing transplantation tolerance (2018) (0)
Preconditioning of NOD mice with anti-CD8 mAb and co-stimulatory blockade enhances chimerism and tolerance and prevents diabetes while depletion of αβ-TCR and CD4 cells negates the effect Running title: DIABETES PREVENTION VIA CHIMERISM (2004) (0)
CD154 Blockade Prevents Allosensitization through Inhibiting Both T- and B-Cell Activation and Decreasing Expression of IFN-γ and IL-10 in T-Cells. (2007) (0)
The Specificity and Management of Vascularized Composite Tissue Allotransplant in Sensitized Recipients (2014) (0)
CD154 BLOCKADE IMPAIRS GENERATION OF CD8+ CD44HIGH/CD62LLOW/− EFFECTOR/MEMORY T-CELLS INDUCED BY BOTH ALLOANTIGEN EXPOSURE AND LYMPHOPENIA AND RESULTS IN PREVENTION OF SENSITIZATION: 454 (2008) (0)
Human CD8+/TCR−/CD56dim/− facilitating Cells Enhance Engraftment of HSC In NOD/SCID/IL2rγnull Recipients. (2010) (0)
Endogenous Bone Marrow–Derived Stem Cells May Be Able to Replace Damaged Retinal Pigment Epithelium in a Murine Model (2006) (0)
CD8+TCR- Graft Facilitating Cells Induce IL-10-Producing B Cells From CD19+CD1d-CD5- B Cells With Potent In Vitro Suppressive Function.: Abstract# D2321 (2014) (0)
CD8+/TCR− Facilitating Cells Induce Generation of Regulatory T cells in Vivo: Chimeric Regulatory T Cells are Antigen-Specific and Enhance Engraftment of Allogeneic HSC in Non-Obese Diabetic (NOD) Mice. (2008) (0)
STEM CELLS PURIFIED FROM BONE MARROW OF FLT3-LIGAND-TREATED MICE EXHIBIT REDUCED ENGRAFTMENT-POTENTIAL (1999) (0)
Stable Mixed Chimerism After Non-Myeloablative Transplant for Sickle Cell Disease: Normal Hematopoiesis Dominates Over Abnormal In Mixed Chimerism (2009) (0)
Mixed xenogeneic bone marrow transplantation f 344 rat plus b 10 mouse equals greater than b 10 mouse results in long term survival of f 344 cardiac grafts across a species barrier (1985) (0)
85: NOD FC exhibit significantly impaired function (2007) (0)
FailureMarrow Transplantation after Engraftment Promotes Engraftment for Secondary Bone Primary Bone Marrow Transplantation CD154:CD40 Costimulatory Blockade at Strategic Nonmyeloablative Conditioning: (2008) (0)
????TCR+ T CELLS AND FC ARE CRITICAL TO ENGRAFTMENT OF DONOR MARROW IN NONOBESE DIABETIC MICE (1999) (0)
Durable Donor Hematopoetic Stem Cell Chimerism is Associated with Protection from Native Renal Disease Recurrence in Recipients of Combined Stem Cell/Kidney Transplants (2018) (0)
Squamous cell carcinoma of the alveolar ridge and palate: A 15-year study (1985) (0)
TREATMENT OF PRE-DIABETIC NOD MICE WITH FLT3-LIGAND IN VIVO DELAYS THE DEVELOPMENT OF DIABETES AND RESTORES THE GENERATION OF MYELOID DENDRITIC CELLS (2004) (0)
HOST CD8+ AND αβ-TCR+ CELLS PLAY A ROLE IN REGULATING ENGRAFTMENT OF SYNGENEIC BONE MARROW (1999) (0)
Innate Immunity Is Responsible for Early Allorejection of Donor Bone Marrow Cells. (2009) (0)
ALTERED EXPRESSION OF RAT PERIPHERAL T-CELL RECEPTOR Vβ REPERTOIRE IN F344-to-B10 (RAT-TO-MOUSE) MIXED XENOGENEIC CHIMERAS (1998) (0)
Human CD8+/TCR−/CD56dim/- Facilitating Cells Facilitate Homing and Engraftment of Human HSC in Vivo (2012) (0)
CAMPATH LYMPHODEPLETION ALLOWS REDUCED INTENSITY CONDITIONING TO ESTABLISH DURABLE MIXED CHIMERISM IN PATIENTS WITH SICKLE CELL DISEASE: 1208 (2008) (0)
STEM CELL PLASTICITY: REGENERATION OF FUNCTIONAL MYOCARDIUM FROM BONE MARROW STEM CELLS (BMSC). (2004) (0)
A Randomized, Controlled, Multicenter, Safety and Efficacy Study of FCR001 Cell-Based Therapy Relative to a Tacrolimus- and Mycophenolate-Based Regimen in De Novo Living-Donor Kidney Transplant Recipients, and Safety in FCR001 Donors (FREEDOM-1 study) (2023) (0)
Bone marrow graft facilitating cells (1995) (0)
Chimerism Following the Induction of Mixed Allogeneic The Abrogation of Allosensitization (2000) (0)
-TCR+ and CD4+ cells negates the effect β α while depletion of blockade enhances chimerism and tolerance and prevents diabetes, Preconditioning of NOD mice with anti-CD8 mAb and costimulatory (2013) (0)
TNFα Mediated Facilitating Cell Enhancement of Hematopoietic Stem Cell Function in Vivo and In Vitro Involves Bcl-3. (2004) (0)
DONOR BONE HARBORS HIGHEST CHIMERISM AND IS SUFFICIENT TO PROMOTE ALLOGRAFT TOLERANCE AFTER HETEROTOPIC HINDLIMB TRANSPLANTATION: 654 (2008) (0)
195: FLT3 expression discriminates HSC subpopulations with differing engraftment-potential (2007) (0)
Abstract 368: Identification of Inducible Nitric Oxide Synthase in Peripheral Blood Cells as a Mediator of Myocardial Ischemia/Reperfusion Injury (2008) (0)
Human CD8+TCR- Facilitating Cells (FC) Upregulate Priming Factors That Enhance Proliferation of HSPC and Increase Responsiveness of HSPC to an SDF-1 Homing Gradient.: Abstract# D2778 (2014) (0)
Hematopoietic cells "facilitatory" and their use (1993) (0)
A Modified Model with Allogeneic Hindlimb Osteomyocutaaneous Flap for the Study of Composite Tissue Allotransplantation in Rats (2006) (0)
CD8+/TCR− graft facilitating cells enhance HSC function via induction of low levels of TNF-α (2006) (0)
The CXCR4 Antagonist AMD 3100 Induces Rapid Mobilization of Facilitating Cells and Hematopoietic Stem Cells in Mice (2011) (0)
Simultaneous bone marrow and tissue transplantation in rats treated with a nonmyeloablative conditioning regimen promote tolerance to composite tissue allografts (141.18) (2009) (0)
A Single-Arm, Multicenter, Open-Label, Proof-of-Concept Safety and Efficacy Study of FCR001 Cell-Based Therapy in Adults with Early Rapidly Progressive Diffuse Cutaneous Systemic Sclerosis at Risk for Organ Failure (FREEDOM-3) (2023) (0)
A Critical and Synergistic Role of TGF-beta and IL-2 Nonlytic Fusion Proteins in Promoting Allogeneic Engraftment and Donor-Specific Tolerance (2012) (0)
enabling human cells and uses thereof (2011) (0)
Bone Marrow-Derived Very Small Embryonic-Like Cells: β-Cell Regeneration in Pancreatic Tissue (2012) (0)
IMMUNE-BASED CONDITIONING TO ESTABLISH CHIMERISM INDUCES TOLERANCE TO COMPOSITE TISSUE ALLOTRANSPLANTS: 299 (2010) (0)
Flt3-Ligand Plays a Critical Role in Restoring Function of NOD Facilitating Cells. (2007) (0)
DIFFERENT T CELL DEPLETION METHODS RESULT IN DIFFERENT NUMBERS OF CELLS WITH NATURAL KILLER SURFACE MARKERS AND CYTOLYTIC ACTIVITY AFTER LONG-TERM CULTURE OF MOUSE BONE MARROW CELLS (1992) (0)
The Early Rejection of Allogeneic BMC by Macrophages or NK Cells Is TRIF Signaling Dependent (2012) (0)
Evidence That CXCR4 + Neural Tissue-Committed Stem Cells (TCSC) Reside/Hide out in the Bone Marrow and Are Mobilized into the Peripheral Blood during Stroke. (2004) (0)
Five Year Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Mismatched Living Donor Renal Transplant Recipients.: Abstract# 2962 (2014) (0)
Selected Bibliography on Small Clinical Trials (2001) (0)
Chimerism May Prolong Islet Allograft Acceptance through the Preservation of CD4 + CD25 + FoxP3 + T reg in Diabetic NOD Mice. (2007) (0)
SENSITIZATION RESULT IN ACCELERATED BUT NOT HYPERACUTE REJECTION OF COMPOSITE TISSUE ALLOTRANSPLANTS: 472 (2010) (0)
Bone Marrow Cell Rejection by Innate Immune Pathways Is Exclusively Dependent On the TRIF Pathway. (2009) (0)
In vitro and in vivo Differentiation of Bone Marrow–Derived Stem Cells Into Retinal Pigment Epithelial–Like Cells (2006) (0)
New frontiers and new technologies (2015) (0)
In the Absence of Preformed Antibody, Sensitized T Cells Mediate an Increased Barrier to Engraftment. (2005) (0)
LOSS AND RECOVERY OF IMMATURE AND MATURE PERIPHERAL BLOOD POPULATIONS FOLLOWING LOW LEVEL TBI AND COMBINED KIDNEY/BONE MARROW TRANSPLANTATION.: Abstract# 1113 (2000) (0)
DEPLETION OF MACROPHAGES AND/OR NK CELLS IN COMBINATION WITH T CELL TARGETING BASED STRATEGIES ELIMINATES THE REQUIREMENT OF IRRADIATION FOR ENGRAFTMENT: 235 (2010) (0)
Chimerism, Lymphocyte Recovery, and the Absence of Graft-Versus-Host Disease in Recipients of Mismatched Unrelated Combined Kidney and HSC Transplants for Tolerance Induction (2011) (0)
Hematopoietic Stem Cell chimerism without Total Body Irradiation in CD8 knock-out mice Conditioned with Cyclophosphamide (1999) (0)
Maintenance of Chimerism Induction of Donor-Specific Tolerance and Production of Donor T Cells Is Critical for Schanie and (2004) (0)
The Potential Clinical Application of Induced Tolerogenic Macrophages. (2022) (0)
Flt3-Ligand Plays a Critical Role in Development and Function of CD8 + /TCR − Facilitating Cells in Bone Marrow, (2011) (0)
PROSPECTIVE ANALYSIS OF THE IMMUNOLOGIC PROFILE OF A HAND TRANSPLANT RECIPIENT IN THE FIRST YEAR: 2298 (2008) (0)

This paper list is powered by the following services:

Other Resources About Suzanne Ildstad

en.wikipedia.org

What Schools Are Affiliated With Suzanne Ildstad?

Suzanne Ildstad is affiliated with the following schools:

Suzanne Ildstad's Academic­Influence.com Rankings

Suzanne Ildstad's Degrees

Why Is Suzanne Ildstad Influential?

Suzanne Ildstad's Published Works

Published Works

Other Resources About Suzanne Ildstad

What Schools Are Affiliated With Suzanne Ildstad?

Suzanne Ildstad's AcademicInfluence.com Rankings